DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

Stefan Bennewitz

VEROVACCiNES

Halle, Germany

14 profile visitsCompanies/Industry

My organisation

VEROVACCiNES has developed a next-generation agile vaccine platform that enables rapid development of vaccines tailored to pathogen dynamics and geographically different strains, delivering faster availability, broader protection, improved scalability, and reduced development risk compared with classic vaccines. The company internally develops high-value vaccines with strong differentiation and validated its platform through the positive opinion of EMA and subsequent EU-wide marketing authorization of the VeroBlue-3 bluetongue virus serotype 3 vaccine. With this milestone, VEROVACCiNES has matured into a fully integrated vaccine developer capable of rapidly generating, developing, and registering vaccines across the EU.
Read more

About me

Additional questions

Interests

VaccinesRegulatory AffairsLivestockFinancing / Investment / FundingEnabling technology (assay, delivery, formulation, manufacturing, ...)

What is your primary goal for attending this event?

Networking with industry professionalsLearning about the latest trends in healthtechUnderstanding regulatory and policy developments